Invesco Ltd.

Position in PBYI — Puma Biotechnology, Inc.

CIK 914208 Atlanta, GA

Position in PBYI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,441,124

+$1,833,794 QoQ

Shares Held

301,002

+216.7% QoQ

Ownership

0.583%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 160 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. PBYI ranks #108 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,441,124	301,002	+216.7%	Shares	Defined	2026-08-14
2026-03-31	$607,330	95,044	-12.2%	Shares	Defined	2026-05-12
2025-12-31	$644,389	108,301	+69.7%	Shares	Defined	2026-02-19
2025-09-30	$338,867	63,817	+27.7%	Shares	Defined	2025-11-13
2025-06-30	$171,437	49,982	+32.8%	Shares	Defined	2025-08-13
2025-03-31	$111,386	37,631	+88.9%	Shares	Defined	2025-05-12
2024-12-31	$60,767	19,924	+6.3%	Shares	Defined	2025-02-13
2024-09-30	$47,790	18,742	-84.2%	Shares	Defined	2024-11-12
2024-06-30	$387,392	118,832	+902.4%	Shares	Defined	2024-08-13
2022-03-31	$34,142	11,855	+0.3%	Shares	Defined	2022-05-16
2021-12-31	$35,932	11,820	-23.1%	Shares	Defined	2022-02-14
2021-09-30	$107,743	15,370	+19.8%	Shares	Defined	2021-11-15
2021-06-30	$117,732	12,825	+18.3%	Shares	Defined	2021-08-17
2021-03-31	$105,412	10,845	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.